3 completed, 1 not yet recruiting, 1 withdrawn. 2 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Not applicable | 1 | Not yet recruiting 1 |
Follow Carcinoma of the Vulva: new trials by email Literature Review of Carcinoma of the Vulva trials Research Report on Carcinoma of the Vulva
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs Stage III Breast Cancer, Stage IV Breast Cancer | Withdrawn | Travera Inc | 2024-11-01 | 2024-11-25 | ||
| Alpha Radiation Emitters Device for the Treatment of Primary and Recurrent Squamous Cell Carcinoma of the Vulva (DaRT). DaRT seeds - Carcinoma of the Vulva, Recurrent Carcinoma of the Vulva | Not applicable | Not yet recruiting | Alpha Tau Medical LTD. | 10 | 2024-04-01 | 2024-01-31 |
| Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) Pleural Effusion, Malignant, Ascites, Malignant | Completed | Travera Inc | 72 | 2022-07-15 | 2026-04-13 | |
| Image-Guided Gynecologic Brachytherapy Image-guided brachytherapy, 3'-Deoxy-3'-18f-Fluorothymidine - Cervical Cancer, Uterine Cancer | Phase 2 | Completed | Dana-Farber Cancer Institute | 93 | 2011-09-01 | 2023-03-14 |
| Safety Study Of Avastin And Pelvic Radiation In Women With Recurrent Gynecological Cancers Avastin - Cervical Cancer, Endometrial Cancer | Phase 2 | Completed | Dana-Farber Cancer Institute | 21 | 2007-05-01 | 2017-03-15 |
Vulvar Neoplasms (5) · Uterine Cervical Neoplasms (4) · Ovarian Neoplasms (3) · Anus Neoplasms (2) · Appendiceal Neoplasms (2) · Breast Neoplasms (2) · Carcinoma (2) · Carcinoma, Hepatocellular (2) · Carcinoma, Neuroendocrine (2) · Carcinoma, Non-Small-Cell Lung (2) · Carcinoma, Renal Cell (2) · Cholangiocarcinoma (2) · Esophageal Neoplasms (2) · Laryngeal Neoplasms (2) · Lung Neoplasms (2)
Female Urogenital Diseases (5) · Female Urogenital Diseases and Pregnancy Complications (5) · Genital Diseases (5) · Genital Diseases, Female (5) · Genital Neoplasms, Female (5) · Neoplasms by Site (5) · Urogenital Diseases (5) · Urogenital Neoplasms (5) · Vulvar Diseases (5) · Neoplasms (4) · Uterine Cervical Diseases (4) · Uterine Diseases (4) · Adnexal Diseases (3) · Endocrine Gland Neoplasms (3) · Endocrine System Diseases (3)
Bevacizumab (1) · Brachytherapy (1) · alovudine (1)
Dana-Farber Cancer Institute (2) · Travera Inc (2) · Alpha Tau Medical LTD. (1)
United States (3)
Mark Stevens, Ph.D. (1) · Mark Stevens, Phd (1) · Martin King, MD, PhD (1) · Paul Nguyen, MD (1) · Rob Kimmerling, Phd (1) · Robert Kimmerling, Ph.D. (1)